Pfiz­er to make an al­most $1B in­vest­ment in its Dublin man­u­fac­tur­ing fa­cil­i­ty — re­port

Ire­land has be­come a hot spot for ma­jor phar­ma­ceu­ti­cal man­u­fac­tur­ing de­vel­op­ments this year, with Pfiz­er as the lat­est to get in on the ac­tion.

Ac­cord­ing to a re­port from the Irish fi­nan­cial news site the Busi­ness Post, sources claim that the phar­ma is plan­ning to in­vest north of €1 bil­lion ($987 mil­lion) for a new man­u­fac­tur­ing fa­cil­i­ty at its Grange Cas­tle site in the Irish cap­i­tal of Dublin.

Sources told the Busi­ness Post that con­struc­tion on the site will be­gin some­time in Q2 of next year, with the project ex­pect­ed to be com­plet­ed by 2026. How­ev­er, no oth­er de­tails were avail­able from the Post, and Pfiz­er did not pro­vide any specifics on the project.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER